Protein-Protein Interactions : Pathophysiological and Therapeutic Aspects . Volume II / by Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar
By: Poluri, Krishna Mohan, autor
Contributor(s): Gulati, Khushboo, autor
| Tripathi, Deepak Kumar, autor
| Nagar, Nupur, autor
Material type:
E-bookPublisher: Singapore : Springer Nature , 2023Edition: 1st ed 2023.Description: 1 recurso en línea.ISBN: 9789819924233.Subject: Proteínas
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias e Ingeniería | QP551 2023 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook04012541 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| QP551 2022 EB Computer Simulations of Aggregation of Proteins and Peptides | QP551 2022 EB TGF-Beta Signaling : Methods and Protocols | QP551 2022 EB VEGF Signaling : Methods and Protocols | QP551 2023 EB Protein-Protein Interactions : Pathophysiological and Therapeutic Aspects Volume II | QP551 2023 EB Protein Folding Dynamics and Stability : Experimental and Computational Methods | QP551 2023 EB Protein Reviews Volume 23 | QP551 2023 EB Integrins in Health and Disease : Key Effectors of Cell-Matrix and Cell-Cell Interactions |
Chapter 1: Protein Networks in Human Disease -- Chapter 2: Protein-Protein Interactions in Cancer -- Chapter 3: Protein-Protein Interactions in Neurodegenerative Diseases -- Chapter 4: Protein-Protein Interactions in Immune Disorders and Inflammation -- Chapter 5: PPIs in Host-Pathogen Interactions -- Chapter 6: Drug Design methods to regulate protein-protein interactions -- Chapter 7: Small molecule inhibitors of Protein-Protein Interactions as Therapeutics.
The second volume of the book-Protein-Protein Interactions (PPIs) provides an overview of various protein-protein interactions (PPIs) that are involved in various human diseases including cancer, neurodegenerative diseases, immune diseases, and inflammation. It summarizes the structure and ligand-based drug designing approaches for the discovery of small molecules that can inhibit PPIs in these diseases. The book discusses different computational and experimental tools that are used to determine the anomalous interactions underlying the diseases. Lastly, it also reviews the classical interactions between pathogens and hosts that are responsible for the pathophysiology of infectious diseases.
There are no comments on this title.